Corvus Pharmaceuticals Inc

+0.01 (+0.66%)
4:52:15 PM EDT: $1.53 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Corvus Pharmaceuticals Inc Stock, NASDAQ:CRVS

863 Mitten Road, Suite 102, Burlingame, California 94010
United States of America
Phone: +1.650.900.4520
Number of Employees: 29


Corvus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in Burlingame, CA.